Why Is BioNTech Stock Surging on Wednesday?
In brief
BioNTech’s stock surged after positive interim data and a 2026 late‑stage roadmap, lifting investor confidence in its mRNA cancer platform.
ClearTape summarizes context in-app. For the full publisher article, use Read original source above.